AMARILYS ROQUE BAZ: Open Payments
NPI 1215503305 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,787 in 120 payments from 17 companies in 2025. Trend: 2023 $2,584 · 2024 $2,729 · 2025 $2,787
Food & beverage: $2,787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $643 |
| UCB, Inc. | 14 | $379 |
| Eisai Inc. | 6 | $261 |
| CATALYST PHARMACEUTICALS, INC. | 9 | $238 |
| ACADIA Pharmaceuticals Inc | 10 | $213 |
| Biogen, Inc. | 8 | $190 |
| PFIZER INC. | 10 | $142 |
| Lundbeck LLC | 5 | $132 |
| Neurelis, Inc. | 6 | $115 |
| Aucta Pharmaceuticals, Inc. | 7 | $102 |
Products named: Leqembi, QULIPTA, FYCOMPA, UBRELVY, DAYBUE, Nayzilam, Fintepla, BOTOX.
Industry payments across FL — which companies pay providers there.
